A shadow market for unlicensed slimming medications is being driven by social media fitness personalities and vendors on communication apps, based on new investigations.
Experimental Treatment Acquiring Popularity Online
The experimental drug, which remains in research studies, is being promoted by social media influencers for its supposed weight-reducing effects. Followers are urged to contact these profiles privately for supplier links, while also receiving discount codes.
Thriving Trade on Social Networks
Separately, a flourishing market exists on messaging services, where communities with thousands of participants share “before and after” photos, injection guides and claims of rapid UK delivery. Vendors market the substance there before directing customers to other platforms for transactions.
Learning About The Experimental Drug
This medication is an investigational injectable developed by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help patients reduce up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being hailed online as the next Ozempic.
Healthcare Experts Voice Worries
Nevertheless, doctors and chemists have cautions that the distribution of what remains an unlicensed medication in the UK is a cause for concern and could lead to individuals injecting products of uncertain source.
Some experts said the demand for the experimental drug could be linked to the increasing price of licensed weight loss products such as Mounjaro.
Legal Position and Implementation
Selling the unapproved drug on social media or messaging apps is illegal in the UK, as it is an unapproved medication that cannot be promoted or distributed for human use under the British medical regulations.
Several influencers attempt to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but advertising and supply can still violate medicines, advertising, and customer laws, potentially leading to fines, legal action or imprisonment.
Service Response and Content Removal
According to TikTok, the platform has removed problematic content and banned related hashtags and query recommendations. The organization said it was committed to maintaining the service safe and allocating resources in strengthening enforcement strategies.
Online Marketplace Activities
Research also found communities with up to nine thousand participants marketing the experimental drug using Telegram's integrated search feature, which operates like a public directory. Entering “retatrutide” instantly brings up channels with thousands of members, populated with photos of slimming results, positive reviews and detailed guides for preparing or injecting at residence.
Within moments of joining one group, a vendor shared WhatsApp details, where most purchases occur. The seller provided an instruction manual and promised delivery within two days. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. Not one asked about weight, medical conditions or past usage.
Product Information and Costs
Within these groups, posts show black plastic parcels with Royal Mail stickers, stating to include new batches. One message stated: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, prepared at residence with purified liquid, or ready-to-use injectors typically priced at £160 for 20mg. When questioned how much time a injector should be used, sellers give conflicting answers ranging from a few weeks to “depends on your body”.
Service Oversight and Security Measures
A representative for Telegram said it actively moderated dangerous material on its platform including content that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Warnings
“Individuals are injecting substances they cannot confirm. Although the research behind this drug is valid, these digital products may not contain what they claim,” said Jason Murphy, the head of pharmaceutical services at Chemist4U.
A medical professional of Asda Online Doctor linked the increase in demand to current cost increases for approved weight-loss medications such as Mounjaro. “With costs increasing, patients are using social media. But fake injections are extremely dangerous. You cannot know what’s inside or whether the conditions they were produced in was clean,” she said.
Her staff has previously encountered individuals injured by personal administration from unverified suppliers. “We recognize the frustration, but buying from messaging apps or communication platforms is taking chances with your health,” said Wyllie. “These substances could be impure or improperly measured.”
Manufacturer Position
A representative from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been evaluated or authorized by any regulatory agency globally. “Consequently at this time no one can market [it] for human use,” they explained, noting that any item “falsely representing itself as a Lilly experimental product not yet approved … may expose users to potentially serious health risks”.
